|
Robert Stude recently joined Prologue as Vice President of Clinical Operations. He is responsible for overseeing the Monitoring Services, Site Services and Clinical Services groups as well as coordinating with the Project Management and Business Development departments to both insure the quality, on-time progression of current studies and help secure new business opportunities for future trials.
Mr. Stude has nearly 25 years of experience in the pharmaceutical industry and over 15 years of work in the CRO realm. His particular expertise lies in the efficient coordination and consolidation of field monitoring and project startup activities. Prologue's clients will especially benefit from his vast knowledge of global site services, safety, and unique processes for optimizing monitoring visits and the time to initiate patient accrual.
Prior to joining Prologue, Mr. Stude held various positions at pharmaceutical companies such as Lexis Pharmaceuticals and KV Pharmaceutical Company, where he handled regulatory and clinical affairs as well as directed project development. Upon moving into the CRO world, where he held senior positions at ClinTrials Research, Celeris, i3 Statprobe, and Integrium, Mr. Stude became intimately involved with project management, monitoring, and clinical services. His background makes him an excellent fit for the Prologue team, and should make a dramatic impact on the further growth and development of 'The Oncology CRO'.
In addition, Mr. Stude is a trained scientist and expert in radiology, possessing a certification in radiation technology from Duke University Medical Center. He is also a member of the Drug Information Association (DIA) and the Association of Clinical Research Professionals (ACRP). | 